Novo Nordisk launches DKK 11.2 billion B-share buyback for May 2026-February 2027

The repurchase forms part of a broader DKK 15 billion program that began in February 2026 and has already included earlier buybacks since then.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.